Trump Prepares 'historic Executive Order' On Drugs In U.S.
19- 12.05.2025, 9:14
- 9,680
Such a move should save the U.S. "trillions of dollars."
US President Donald Trump is about to sign an executive order to lower prescription drug prices. Such a move should allow the US to save "trillions of dollars."
This was reported by Bloomberg with reference to Trump's publication in Truth Social.
The American president noted in his publication in the social network that he plans to sign the relevant decree on Monday, May 12.
Trump predicted that pharmaceutical prices in the U.S. could fall by 30 to 80 percent.
At the same time, he said, drug prices would likely "rise around the world to equalize and, for the first time in many years, bring fairness to America."
Trump announced his intention to ensure that the U.S. pays "the same price for drugs as the nation that pays the lowest price anywhere in the world."
"Our country will finally be treated fairly, and our citizens' health care costs will be reduced by an amount never even thought of before," the American president said in Truth Social.
U.S. Drug Prices
Americans pay more for drugs than any other country in the world, driving innovation and spurring growth in the pharmaceutical industry, Bloomberg notes.
Drug makers have previously said modernizing the system would cut revenue and "stifle" the development of breakthrough treatments that could extend and improve lives.
The U.S. government is now negotiating the price of some of the most expensive drugs used in Medicare under the Inflation Reduction Act. It was passed in 2022 under past U.S. President Joe Biden.
The first two rounds of drug price negotiations in the States did not include drugs prescribed by doctors, but the next round could be.
Trump's plan to lower drug prices
In his first term as president, Trump proposed a Medicare pilot program in the United States for drugs without competition from low-cost generics provided in doctors' offices.
The leader said at the time that he wanted to bring prices in line with countries such as France and Japan, where they cost significantly less.
That plan Trump pursued for three years was intended to ensure that Medicare would pay the lowest price offered to a group of 22 countries.
The effort was struck down in U.S. federal court after pharmaceutical companies appealed it. They argued that the administration had not properly followed the rulemaking process.
Additionally, the Biden administration did not appeal the finding, but passed legislation that led to the Inflation Reduction Act.
Bank's name: Bank Millennium S.A.
Address: ul. Stanislawa Zaryna, 2A, 02-593, Warszawa
IBAN: PL97116022020000000216711123
SWIFT: BIGBPLPW
Name of the account holder: Fundacja “KARTA ‘97”
Purpose/title of payment: Donation for statuary aims
You can contact us by the e-mail [email protected]
